Back to search

Etoposide, cisplatin and doxorubicin in patients with small cell lung cancer: Tumor response and long term survival

Data up to Jan 2025

Published1986
Citations17
References21

Total Citations Per Year

Abstract

References (21)

cis-Dichlorodiammineplatinum(II): combination chemotherapy and cross-resistance studies with tumors of mice.

1979 • 405 citations

Histological Typing Of Lung Tumors

1968 • 383 citations

Etoposide (VP-16) and cisplatin: an effective treatment for relapse in small-cell lung cancer.

1985 • 188 citations

VP-16-213 monotherapy for remission induction of small cell lung cancer: a randomized trial using three dosage schedules.

1978 • 166 citations

Studies of cross-resistance, synergistic combinations and blocking of activity of platinum derivatives

1978 • 160 citations

Role of chemotherapy in small cell lung cancer: a consensus report of the International Association for the Study of Lung Cancer workshop.

1983 • 145 citations

Etoposide (VP-16): Current Status and New Developments

1985 • 143 citations

Role of radiation therapy in small cell anaplastic carcinoma of the lung.

1983 • 107 citations

Cisplatin and etoposide combination chemotherapy for refractory small cell carcinoma of the lung

1986 • 72 citations

Cisplatin, adriamycin, and etoposide (cav) for remission induction of small-cell bronchogenic carcinoma. Evaluation of efficacy and toxicity and pilot study of a “late intensification” with autologous bone-marrow rescue

1982 • 67 citations

Chemotherapy of small cell carcinoma of the lung with V. P. 16–213

1978 • 65 citations

Treatment of small cell anaplastic carcinoma of the lung with the oral solution of VP-16-213 (NSC 141540, 4′-demethylepipodophyllotoxin 9-(4,6-0-ethylidene-β-D-glucopyranoside)

1977 • 58 citations

VP-16-213 versus polychemotherapy in patients with advanced small cell lung cancer.

1976 • 45 citations

Epipodophyllotoxin (VP16-213) in small cell carcinoma of the bronchus resistant to initial combination chemotherapy

1982 • 29 citations

World Conference on Lung Cancer

2003 • 28 citations

cis-Dichlorodiammineplatinum (II) in small cell anaplastic bronchogenic carcinoma: a phase II study.

1979 • 25 citations

Phase II trial of cisplatin in small cell carcinoma of the lung.

1981 • 21 citations

Etoposide--an effective single drug for treating bronchogenic carcinoma.

1982 • 16 citations

VP16-213 combined with cis-platinum (CDDP) in the treatment of small cell carcinoma of the lung (SCLC)

1982 • 12 citations

Adriamycin: Activity in Solid Tumors

1975 • 9 citations

Deleted Work

1955 • 0 citations

Cited By (0)

No citing papers found in database

Etoposide, cisplatin and doxorubicin in patients with small cell lung cancer: Tumor… (1986) – European Journal of Cancer and Clinical Oncology | Metascience Observatory Explorer